Intravenous (IV) administration of the antiplatelet agent tirofiban for 72 hours was associated with a reduction in early neurologic deterioration compared with oral aspirin therapy in patients with acute ischemic stroke, in the randomized TREND trial.
www.medscape.com/viewarticle/...
medscape.com
Tirofiban Reduces Early Neurologic Deterioration After Stroke
Intravenous tirofiban over 72 hours reduced early neurologic deterioration compared with oral aspirin in patients with acute ischemic stroke, in the randomized TREND trial.